ADCYAP1 and prostate carcinoma: Anti-apoptotic action of PACAP could not only be detected in nontumorous cells, but also in PC-3 human prostate cancer cells, where PACAP exerted a cell viability improving effect against serum deprivation induced apoptosis with increased Bcl-2 and procaspase-3 levels [131].